Fidelity SPDR Advertisement
Home > Boards > Stock Clubs > Overvalued/Short Sellers > The Day Shorters Room

Like which stock RARS?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
RacksOnRacks Member Profile
 
Followed By 8
Posts 370
Boards Moderated 0
Alias Born 08/01/11
160x600 placeholder
Roche Hit By Failure Of Cancer Drug Trial
Roche said a late-stage study of its breast cancer drug Kadcyla failed to yield superior results to an existing treatment, damaging the outlook for stronger sales in one of its key drug markets.
More Top Equities Stories Of The Day
Deezer Names New CEO Before Full U.S. Launch
Repsol to Buy Talisman Energy for $8.3 Billion --Update
How a Memo Cost Big Banks $37 Billion
Mobile's Rise Poses a Riddle for Banks
U.S. Hot Stocks: Hot Stocks to Watch
ADR Shares End Lower; BT Group Shares Trade Actively
T-Mobile Offers to Roll Over Data -- Update
Hungary to Sell MKB Bank After Revamp by Central Bank - Prime Minister
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist